RGC

REGENCELL BIOSCIENCE HLDGS L

RGC·G7487R100·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

RGC (REGENCELL BIOSCIENCE HLDGS L) is held by 26 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($2.6M), Alyeska Investment Group, L.P. ($2.5M), Legal & General Group Plc ($778,974). Net institutional sentiment: Mixed.

26
Holders
(1 Elite)
$8.4M
Total Value
63% (32)
Consensus
20 buying - 12 selling
13F: Insider & Congress: Updated regularly
RGC

Smart Money Verdict

View all
Loading verdict
Held by 26 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Jul 11, 2025 · Congress none

ActivistR(Regencell (BVI) Limited86.2%Jul 11, 2025

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
422,011(+1.6%)$2.6M0.0%-67.52%
27
New
416,261$2.5M0.0%-9.69%
36
Increased
128,000(+1192.5%)$778,9740.0%-26.42%
40
New
98,348$598,9400.0%-9.69%
37
New
60,061$365,7710.0%-9.69%
33
Increased
47,159(+448.7%)$287,1980.0%-41.19%
38
Increased
43,208(+80.9%)$263,1370.0%-64.46%
24
New
41,750$254,2580.0%-9.69%
32
New
23,129$140,8560.0%-9.69%
34
Decreased
22,036(-17.2%)$134,1990.0%-68.66%
0
New
15,292$93,1280.0%-9.69%
30
Decreased
14,994(-12.7%)$91,3130.0%-77.07%
0
New
14,406$87,7330.0%-9.69%
30
Decreased
11,199(-62.1%)$68,2020.0%-71.01%
0
Decreased
5,052(-74.8%)$30,7680.0%-68.15%
0
Decreased
4,925(-0.7%)$29,9940.0%-67.29%
0
Increased
2,803(+25.6%)$17,0700.0%-72.96%
23
Increased
1,831(+1830x)$11,1510.0%-9.83%
19
New
1,717$10,4560.0%-9.69%
26
Increased
953(+169.2%)$5,8040.0%-56.83%
17

Showing 1-20 of 33

1 / 2
RGCRGCREGENCELL BIOSCIENCE HLDGS L

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used